Roy D. Baynes - Director at Travere Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
TVTX on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Roy D. Baynes since 12/25/2023

Holdings reported by Roy D. Baynes for Travere Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 31K $209K $6.74 May 8, 2024 Direct
Stock option (right to buy) 19.5K May 8, 2024 Direct Common Stock

Transactions reported by Roy D. Baynes for Travere Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.